Canopy Growth Corp: Will it Ever Be a Buy?

Canopy Growth Corp (TSX:WEED) keeps going lower. Will it ever find a bottom?

| More on:
Pot stocks are a riskier investment

Image source: Getty Images

Canopy Growth Corp (TSX:WEED) has been the limbo bar of stocks: when you think it can’t go lower, it goes lower still. Technically, the stock is currently up from its post-legalization low of $0.50, set back in July. However, it’s still down 99% from the highs set just before legalization.

The question has to be asked:

Will this stock ever be a buy?

WEED stock is currently inexpensive by some measures. For example, it has a price/book ratio of exactly one, which is low by the standards of today’s market. However, the company keeps losing money and spending its cash pile, which means the “book value” in the denominator of the aforementioned price/book ratio is shrinking. It’s only natural for a value investor to feel tempted by a stock that’s flirting with all-time lows, but nevertheless, red flags remain. In this article, I will explore the question of whether Canopy Growth Corp stock will ever be a buy.

Revenue declining

In its most recent quarter, Canopy Growth Corp managed to eke out slightly positive revenue growth of 2.5%. This was a good showing for Canopy, as its revenue has mostly been declining lately. In the trailing 12-month period, the company’s revenue declined 12.8%. Over the last three years, its revenue declined by 8.3% CAGR. Revenue is still up by an impressive 31.5% CAGR over the last five years, but remember that five years ago, the stock went for $42. Overall, the recent story of Canopy Growth Corp is one of persistent decline.

Persistent losses

Another thing that Canopy has been very persistent about over the last few years is losing money. In its most recent quarter, it lost $31 million. In the prior-year quarter, it lost a full $2 billion! Granted, the loss witnessed in the previous quarter was much improved from a year before. But still, it was significant. Back in 2018, Canopy got a $5 billion investment from Constellation Brands, a U.S. beverage company. Today, the cash pile that came from that deal is down to $533 million. So, Canopy’s losses have not just been on paper accounting losses. The company has been genuinely bleeding cash.

This all has bearing on WEED’s valuation. The stock is optically cheap, with low price/sales and price/book ratios. However, sales and book value are both declining. If Canopy keeps burning cash at the rate it has been since the 2018 Constellation Brands investment, it will eventually have no book value to speak of. Should that occur, the stock will not look to have been cheap at today’s prices.

The final verdict

Having reviewed the pertinent valuation and financial performance metrics, I’m prepared to deliver a verdict on whether Canopy Growth Corp stock will ever be a buy.

First things first, I do not consider it a buy now. We’ll need to see at least another quarter’s earnings before we can be sure the cash burn and book value disappearance can be mitigated.

As for whether the stock can ever be a buy, well, it’s possible. If the company cuts costs enough it may someday become profitable. However, cannabis is a commodity, one with lots of suppliers. I wouldn’t touch stocks in this industry until after a few big name producers go out of business. Then and only then will cannabis be interesting.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Button has no position in any of the stocks mentioned. The Motley Fool recommends Constellation Brands. The Motley Fool has a disclosure policy.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »